PROVECTUS BIOPHARMACEUTICALS, INC. · Lacey John III · Director
Filed Jul 01, 2026, 01:20 AM·Transaction Jun 30, 20260001493152-26-031403
Generate a plain-language summary of what happened in this filing, who traded, the approximate value, and why it may or may not matter.
Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
| Filed | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|
3h ago Jun 30, 2026 | Buy · A | 48,917 | $0.00 | $0 | Neutral+2 | Deriv |
Heuristic score. Higher = more bullish-leaning insider activity. Not financial advice.